A healthy, immunocompetent pregnant patient at 33 weeks' gestation presents in October during RSV season. She has not received any RSV product this pregnancy. What is the recommended preventive strategy?AAdminister infant nirsevimab at birth and avoid maternal RSV vaccinationBAdminister a single dose of maternal RSVpreF vaccine at 32-36 weeks' gestationCGive the maternal RSV vaccine at 20 weeks' gestationDDelay all RSV prophylaxis until after deliveryEAdminister both maternal RSV vaccine now and infant nirsevimab at birthCheck my answer